Abstract
The role of the immune system in myelodysplastic syndrome (MDS) progression has been widely accepted, although mechanisms underlying this immune dysfunction are not clear. CD4(+) and CD8(+) lymphocyte profiles in the peripheral blood of MDS patients were evaluated and correlated with clinical characteristics, the expression of FOXP3 and the anti-inflammatory cytokines IL10, TGFβ1 and CTLA4. IL10 expression inversely correlated with the percentage of CD8(+) cells and was higher in high-risk MDS. Our findings provide further evidence for the role of T cell-mediated IL10 production in MDS and strengthen the idea of distinct cytokine profiles in low and high-risk MDS.
Copyright © 2013 Elsevier Ltd. All rights reserved.
Publication types
-
Clinical Trial
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adult
-
Aged
-
Aged, 80 and over
-
CD4-Positive T-Lymphocytes / metabolism
-
CD4-Positive T-Lymphocytes / pathology
-
CD8-Positive T-Lymphocytes / metabolism*
-
CD8-Positive T-Lymphocytes / pathology
-
CTLA-4 Antigen / blood
-
Female
-
Forkhead Transcription Factors / blood
-
Gene Expression Regulation*
-
Humans
-
Interleukin-10 / blood*
-
Lymphocyte Count
-
Male
-
Middle Aged
-
Myelodysplastic Syndromes / blood*
-
Myelodysplastic Syndromes / pathology
-
Risk Factors
-
Transforming Growth Factor beta1 / blood
Substances
-
CTLA-4 Antigen
-
CTLA4 protein, human
-
FOXP3 protein, human
-
Forkhead Transcription Factors
-
IL10 protein, human
-
Transforming Growth Factor beta1
-
Interleukin-10